Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition comprising CCN5 as active ingredient, for preventing or treating retinal diseases

Pharmaceutical composition comprising CCN5 as active ingredient, for preventing or treating retinal diseases

US Patent 12377130 · Granted Aug 5, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DC-DC converter and display device including the same2025
Nickel catalyst for hydrogenation reaction and manufacturing method therefor2025
Pharmaceutical composition for prevention or treatment of heart failure2025
Catalyst for hydrogenation reaction and preparation method for same2024
Catalyst for hydrogenation and method for preparing same2024
Hydrogenation reaction catalyst and preparation method therefor2024
Catalyst for hydrogenation reaction and preparation method for same2024
Pharmaceutical composition for preventing or treating cardiac arrhythmia2023
Composition comprising protein phosphatase 1 inhibitory peptide for treating vas2022
Method for measuring aromatic contents in hydrocarbon solution2022
HMD device and method for controlling same2021
Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of ph2021